The level of melatonin is decreased in serum of mice with diabetes-accelerated atherosclerosis, and exogenous supplement of melatonin reduces iNOS expression and S-nitrosylation of GNAI2, thus alleviating diabetes-accelerated atherosclerosis. The gene discussed is GNAI2; the disease is diabetes mellitus.